Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
1,089,490
-
Share change
-
-256,020
-
Total reported value
-
$69,617,547
-
Price per share
-
$63.87
-
Number of holders
-
81
-
Value change
-
-$16,373,437
-
Number of buys
-
24
-
Number of sells
-
37
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2020
As of 30 Sep 2020,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,089,490 shares.
The largest 10 holders included
Peak Asset Management, LLC, Brinker Capital Investments, LLC, Advocacy Wealth Management Services, LLC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, UBS Group AG, ENVESTNET ASSET MANAGEMENT INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.